Follow
Jean-Mathieu Beauregard
Jean-Mathieu Beauregard
Associate Professor of Nuclear Medicine, Université Laval
Verified email at crchudequebec.ulaval.ca - Homepage
Title
Cited by
Cited by
Year
Lutetium-177–PSMA-617 for metastatic castration-resistant prostate cancer
O Sartor, J De Bono, KN Chi, K Fizazi, K Herrmann, K Rahbar, ST Tagawa, ...
New England Journal of Medicine 385 (12), 1091-1103, 2021
15162021
Diagnostic Performance of 18F-DCFPyL-PET/CT in Men with Biochemically Recurrent Prostate Cancer: Results from the CONDOR Phase III, Multicenter Study
MJ Morris, SP Rowe, MA Gorin, L Saperstein, F Pouliot, D Josephson, ...
Clinical Cancer Research 27 (13), 3674-3682, 2021
2562021
Quantitative 177Lu SPECT (QSPECT) imaging using a commercially available SPECT/CT system
JM Beauregard, MS Hofman, JM Pereira, P Eu, RJ Hicks
Cancer Imaging 11 (1), 56-66, 2011
1642011
Personalized 177Lu-octreotate peptide receptor radionuclide therapy of neuroendocrine tumours: initial results from the P-PRRT trial
M Del Prete, FA Buteau, F Arsenault, N Saighi, LO Bouchard, A Beaulieu, ...
European journal of nuclear medicine and molecular imaging 46, 728-742, 2019
1512019
The tumour sink effect on the biodistribution of 68Ga-DOTA-octreotate: implications for peptide receptor radionuclide therapy
JM Beauregard, MS Hofman, G Kong, RJ Hicks
European journal of nuclear medicine and molecular imaging 39, 50-56, 2012
1482012
Personalized 177Lu-octreotate peptide receptor radionuclide therapy of neuroendocrine tumours: a simulation study
M Del Prete, FA Buteau, JM Beauregard
European journal of nuclear medicine and molecular imaging 44 (9), 1490-1500, 2017
1222017
68Ga PET/CT Ventilation-Perfusion Imaging for Pulmonary Embolism: A Pilot Study with Comparison to Conventional Scintigraphy
MS Hofman, JM Beauregard, TW Barber, OC Neels, P Eu, RJ Hicks
The Journal of Nuclear Medicine 52 (10), 1513, 2011
1142011
An automated voxelized dosimetry tool for radionuclide therapy based on serial quantitative SPECT/CT imaging
PA Jackson, JM Beauregard, MS Hofman, T Kron, A Hogg, RJ Hicks
Medical physics 40 (11), 112503, 2013
942013
Pilot comparison of 18F‐fluorocholine and 18F‐fluorodeoxyglucose PET/CT with conventional imaging in prostate cancer
JM Beauregard, SG Williams, TR DeGrado, P Roselt, RJ Hicks
Journal of medical imaging and radiation oncology 54 (4), 325-332, 2010
772010
Impact of point spread function reconstruction on thoracic lymph node staging with 18F-FDG PET/CT in non–small cell lung cancer
C Lasnon, RJ Hicks, JM Beauregard, A Milner, M Paciencia, AV Guizard, ...
Clinical nuclear medicine 37 (10), 971-976, 2012
702012
Accuracy of 177Lu activity quantification in SPECT imaging: a phantom study
CF Uribe, PL Esquinas, J Tanguay, M Gonzalez, E Gaudin, ...
EJNMMI physics 4, 1-20, 2017
672017
Clinical utility of amyloid PET imaging in the differential diagnosis of atypical dementias and its impact on caregivers
MR Bensaïdane, JM Beauregard, S Poulin, FA Buteau, J Guimond, ...
Journal of Alzheimer's Disease 52 (4), 1251-1262, 2016
622016
FDG-PET/CT for pre-operative staging and prognostic stratification of patients with high-grade prostate cancer at biopsy
JM Beauregard, AC Blouin, V Fradet, A Caron, Y Fradet, C Lemay, ...
Cancer Imaging 15, 1-10, 2015
592015
Accuracy and reproducibility of simplified QSPECT dosimetry for personalized 177Lu-octreotate PRRT
M Del Prete, F Arsenault, N Saighi, W Zhao, FA Buteau, A Celler, ...
EJNMMI physics 5, 1-20, 2018
572018
Determination of gamma camera calibration factors for quantitation of therapeutic radioisotopes
W Zhao, PL Esquinas, X Hou, CF Uribe, M Gonzalez, JM Beauregard, ...
EJNMMI physics 5, 1-16, 2018
572018
Potentiation of 177Lu-octreotate peptide receptor radionuclide therapy of human neuroendocrine tumor cells by PARP inhibitor
NK Purohit, RG Shah, S Adant, M Hoepfner, GM Shah, JM Beauregard
Oncotarget 9 (37), 24693, 2018
542018
GLUT1 expression in high-risk prostate cancer: correlation with 18F-FDG-PET/CT and clinical outcome
S Meziou, C Ringuette Goulet, H Hovington, V Lefebvre, É Lavallée, ...
Prostate cancer and prostatic diseases 23 (3), 441-448, 2020
472020
Feasibility of single-time-point dosimetry for radiopharmaceutical therapies
X Hou, J Brosch, C Uribe, A Desy, G Böning, JM Beauregard, A Celler, ...
Journal of Nuclear Medicine 62 (7), 1006-1011, 2021
432021
Assessment of human biodistribution and dosimetry of 4-fluoro-11β-methoxy-16α-18F-fluoroestradiol using serial whole-body PET/CT
JM Beauregard, É Croteau, N Ahmed, JE van Lier, F Bénard
Journal of Nuclear Medicine 50 (1), 100-107, 2009
422009
PSMA theranostics: current landscape and future outlook
H Zhang, S Koumna, F Pouliot, JM Beauregard, M Kolinsky
Cancers 13 (16), 4023, 2021
392021
The system can't perform the operation now. Try again later.
Articles 1–20